Catlett Hematology Advisory Services has extensive clinical experience in the research, diagnosis, and treatment of benign and malignant hematology disorders.

Benign Hematology

• Unexplained cytopenias: anemia, thrombocytopenia, or leukopenia/neutropenia

• Acquired and congenital marrow failure syndromes

• Use of hematologic growth factors

• Iron physiology, iron deficiency and iron overload/hemochromatosis

• Thrombosis and thrombophilia

  • Deep venous thrombosis

  • Arterial thrombosis

  • Cryptogenic stroke

  • Genetic disorders

  • Anti-phospholipid syndrome

    
    

• Disorders of platelet number and function

• Heparin-induced thrombocytopenia

• Bleeding disorders: von Willebrand disease, hemophilia, rare bleeding disorders

• Consumptive coagulopathies:

  • Disseminated intravascular coagulation

    
    

• Immune and non-immune Hemolytic anemia

• Nutritional anemia

  • Iron deficiency anemia

  • B12 deficiency

  • Folate deficiency

    
    

• Anemia of chronic kidney disease

• Sickle cell disease

• Thrombocytopenic purpura (TTP); hemolytic uremic syndrome (HUS); hemolytic anemia, elevated liver enzymes and low platelet (HELLP) syndrome

• Rare disorders: Macrophage activation syndrome/hemophagocytic lymph-histocytosis (HLH)

• Transfusion medicine

Malignant Hematology

• Myelodysplasia

• Leukemia:

  • Acute myelogenous leukemia

  • Acute lymphoblastic leukemia

  • Chronic myelogenous leukemia

  • Chronic lymphocytic leukemia

    
    

• Lymphoma: Hodgkin lymphoma, non-Hodgkin lymphoma

• Plasma cell disorders: monoclonal gammopathy, smoldering myeloma, multiple myeloma, POEMS syndrome, light chain amyloidosis.

• Myeloproliferative neoplasms:

  • Polycythemia vera

  • Primary myelofibrosis

  • Essential thrombocythemia

    
    

• Stem cell transplantation

• Cellular therapies in the treatment of malignant disease